LUMICKS’ z-Movi® Cell Avidity Analyzer enables the measurement and selection of immune cells based on their interactions with cancer cells, providing a new functional biomarker for evaluating immune cell functionality and activation. With this technology, scientists can obtain predictive, reproducible, and fast results to compare several types of immunotherapeutic strategies. To know more
